Watch a video presentation of this article
Watch the interview with the author
Abbreviations
- DSA
Donor Service Area
- ESLD
end‐stage liver disease
- HCC
hepatocellular carcinoma
- SES
socioeconomic status
An accumulating body of evidence points toward the powerful role of social and environmental factors, referred to as the social determinants of health, in shaping disease patterns and outcomes.1, 2 The World Health Organization has defined the social determinants of health (Table 1) as “the conditions in which people are born, grow, live, work, and age.”3 In both the developing and the developed world, social determinants likely have a greater influence on health and disease than medical care alone.2, 4 Because the social determinants of health are fundamental components in the causal pathways of disease, we suggest that focusing on them in the context of liver disease will offer insights into strategies for improving health outcomes for patients with end‐stage liver disease (ESLD) in the United States. In this review, we focus on access to and outcomes after liver transplantation among patients with ESLD.
Table 1.
Social Determinants of Health
| Neighborhood and built environment |
Community‐based resources Public safety Transportation options |
| Social and community context |
Cohesion Residential segregation Community norms |
| Education |
Quality of education Job training Language and literacy |
| Economic stability |
Income/wealth Job market |
| Health and health care |
Access to health care services Exposure to crime and violence Insurance status and ability to pay |
The conditions in which we live are powerful influences on health; many of these topic areas are overlapping. List was modified from Healthy People 2020 (http://www.healthypeople.gov/2020/topics‐objectives/topic/social‐determinants‐health).
Development of Liver Disease
For example, environments that foster low levels of physical activity coupled with dependence on calorie‐rich diets have been linked to the development of maturity‐onset diabetes and obesity, both of which are risk factors for nonalcoholic fatty liver disease.5 Another major cause of cirrhosis in the United States is hepatitis C infection,6 which is associated with low socioeconomic status (SES), drug use, and incarceration.7 In some states, however, incarceration also provides access to treatment that might not otherwise be available to this population.8, 9 Once cirrhosis is established, lower surveillance rates for hepatocellular carcinoma (HCC) are seen in patients with low SES and poor insurance.10, 11 In a previous issue of this journal, Kim and Singal12 reviewed disparities in prevention or early detection of HCC based on patient demographics, provider level factors, and system function.
Access to the Liver Transplant Wait List
Multiple studies have shown that wait‐list rates vary widely by place of residence,13 with decreasing urbanization,14 increasing distance from a transplant center,15 and smaller number of transplant centers in the area16 being associated with lower likelihood of being listed. As in HCC surveillance, these point to multiple environmental issues that need to be overcome to provide better access to the wait list, from neighborhood characteristics to transportation issues to provider availability and awareness of transplantation as an option. In addition, liver transplant programs have identified many social barriers to qualifying for liver transplantation listing, including low education level and inadequate housing.17 Social support, a nearly universal requirement for listing, is a serious concern, because caregiver burden and quality of life are significantly worse than in the national reference population.18 Private health insurance strongly increases the likelihood of being listed.19 Although improving patients' educational attainment may be outside the scope of what a transplant program can provide, health “navigators” have been used effectively in renal transplantation20 and could conceivably be applied to liver transplantation. Similarly, providing transportation, home health aides, and/or visiting nurses may help mitigate the need for patients to provide their own social support.
Wait‐List Outcomes
The allocation system plays a critical role in disparities and access to transplantation. The United States is divided into 58 Donor Service Areas (DSAs), which arose spontaneously from cooperating hospitals under the respective organ procurement organizations. There is considerable variability among DSAs in the likelihood of transplant versus death on the wait list.21 As a theoretical means of overcoming this obstacle, patients are allowed and encouraged to travel to more favorable DSAs to be listed and transplanted, but in reality, this option is available to only a small subset of high SES patients who have the means to relocate or travel long distances on very short notice.22 At the DSA level, evidence suggests that variability in wait‐list outcomes is related to transplant center number and density.13, 16, 21, 23, 24 It is obviously difficult to legislate center location and existence, but a more feasible intervention might be to reorganize DSA boundaries to equalize organ distribution, thus increasing patients' chances at transplantation.25 Such proposals are predicted to improve overall access to transplantation and wait‐list outcomes, but they are undergoing further review and analysis to evaluate unintended effects, in particular, the potential for isolated centers currently serving sparse populations to close because of organs being sent to high‐density centers, paradoxically decreasing access to transplantation.
Posttransplant Outcomes
Posttransplant outcomes are associated with social determinants as well. Although perioperative outcomes of low SES recipients do not differ significantly from those of higher SES, lower SES is associated with an increased risk for death 2 years after transplantation.26 Poor health literacy is associated with unintentional nonadherence,27 which is a risk factor for death and graft failure posttransplant.28 Lower income and limited literacy are also associated with a greater number of posttransplant hospitalizations,27 and it is important to consider whether the cost and effort of up‐front education and providing home health care support would be effective enough to be offset not only by longer graft and patient survival, but also by the savings from decreasing complications and admissions.
Conclusions
Overall access to and outcomes after liver transplantation have improved significantly over the last 50 years because of medical and technical advances, but we are just beginning to understand the profound effect of Social determinants in liver transplantation. More work needs to be done to elucidate the mechanisms behind the observed associations outlined in this review, to intelligently design effective interventions to improve outcomes. Although many potential solutions may fall outside the traditional purview of health care delivery, the health care community would do well to assume responsibility for them.
Potential conflict of interest: Nothing to report.
References
- 1. Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health 2006;27:167‐194. [DOI] [PubMed] [Google Scholar]
- 2. Braveman P, Gottlieb L. The social determinants of health: it's time to consider the causes of the causes. Public Health Rep 2014;129(suppl 2):19‐31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kelly MP. The social determinants of health developing an evidence base for political action. 2007. http://cdrwww.who.int/social_determinants/resources/mekn_final_report_102007.pdf.
- 4. Kawachi I, Subramanian SV, Almeida‐Filho N. A glossary for health inequalities. J Epidemiol Community Health 2002;56:647‐652. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Scaglione S, Kliethermes S, Cao G, Shoham D, Durazo R, Luke A, et al. The epidemiology of cirrhosis in the United States: a population‐based study. J Clin Gastroenterol 2014;49:690‐696. [DOI] [PubMed] [Google Scholar]
- 6. Talwalkar JA. Potential impacts of the Affordable Care Act on the clinical practice of hepatology. Hepatology 2014;59:1681‐1687. [DOI] [PubMed] [Google Scholar]
- 7. Unwin N, Whiting D, Roglic G. Social determinants of diabetes and challenges of prevention. Lancet 2010;375:2204‐2205. [DOI] [PubMed] [Google Scholar]
- 8. Awofeso N. Prisons as social determinants of hepatitis C virus and tuberculosis infections. Public Health Rep 2010;125(suppl 4):25‐33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Rice JP, Burnett D, Tsotsis H, Lindstrom MJ, Cornett DD, Voermans P, et al. Comparison of hepatitis C virus treatment between incarcerated and community patients. Hepatology 2012;56:1252‐1260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Singal AG, Yopp A, S Skinner C, Packer M, Lee WM, Tiro JA. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med 2012;27:861‐867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Singal AG, Li X, Tiro J, Kandunoori P, Adams‐Huet B, Nehra MS, et al. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med 2015;128:90.e1–e7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Kim AK, Singal AG. Health disparities in diagnosis and treatment of hepatocellular carcinoma. Clin Liver Dis 2015;4:143‐145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Mathur AK, Ashby VB, Fuller DS, Zhang M, Merion RM, Leichtman A, et al. Variation in access to the liver transplant waiting list in the United States. Transplantation 2014;98:94‐99. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Axelrod DA, Guidinger MK, Finlayson S, Schaubel DE, Goodman DC, Chobanian M, et al. Rates of solid‐organ wait‐listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008;299:202‐207. [DOI] [PubMed] [Google Scholar]
- 15. Goldberg DS, French B, Forde KA, Groeneveld PW, Bittermann T, Backus L, et al. Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA 2014;311:1234‐1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Adler JT, Dong N, Markmann JF, Schoenfeld D, Yeh H. Role of patient factors and practice patterns in determining access to liver waitlist. Am J Transplant 2015;15:1836‐1842. [DOI] [PubMed] [Google Scholar]
- 17. Flattau A, Olaywi M, Gaglio PJ, Marcus P, Meissner P, L Dorfman EB, et al. Social barriers to listing for adult liver transplantation: their prevalence and association with program characteristics. Liver Transpl 2011;17:1167‐1175. [DOI] [PubMed] [Google Scholar]
- 18. Nguyen DL, Chao D, Ma G, Morgan T. Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients. Ann Gastroenterol 2015;28:124‐129. [PMC free article] [PubMed] [Google Scholar]
- 19. Bryce CL, Angus DC, Arnold RM, Chang C‐CH, Farrell MH, Manzarbeitia C, et al. Sociodemographic differences in early access to liver transplantation services. Am J Transplant 2009;9:2092‐2101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Sullivan C, Leon JB, Sayre SS, Marbury M, Ivers M, Pencak JA, et al. Impact of navigators on completion of steps in the kidney transplant process: a randomized, controlled trial. Clin J Am Soc Nephrol 2012;7:1639‐1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Yeh H, Smoot E, Schoenfeld DA, Markmann JF. Geographic inequity in access to livers for transplantation. Transplantation 2011;91:479‐486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Dzebisashvili N, Massie AB, Lentine KL, Schnitzler MA, Segev D, Tuttle‐Newhall J, et al. Following the organ supply: assessing the benefit of inter‐DSA travel in liver transplantation. Transplantation 2013;95:361‐371. [DOI] [PubMed] [Google Scholar]
- 23. Axelrod DA, Guidinger MK, Finlayson S, Schaubel DE, Goodman DC, Chobanian M, et al. Rates of solid‐organ wait‐listing, transplantation, and survival among residents of rural and urban areas. JAMA 2008;299:202‐207. [DOI] [PubMed] [Google Scholar]
- 24. Adler JT, Yeh H, Markmann JF, Nguyen LL. Market competition and density in liver transplantation: relationship to volume and outcomes. J Am Coll Surg 2015;221:524‐531. [DOI] [PubMed] [Google Scholar]
- 25. Gentry SE, Massie AB, Cheek SW, Lentine KL, Chow EH, Wickliffe CE, et al. Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant 2013;13:2052‐2058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Quillin RC, Wilson GC, Wima K, Hohmann SF, Sutton JM, Shaw JJ, et al. Neighborhood level effects of socioeconomic status on liver transplant selection and recipient survival. Clin Gastroenterol Hepatol 2014;12:1934‐1941. [DOI] [PubMed] [Google Scholar]
- 27. Serper M, Patzer RE, Reese PP, Przytula K, Koval R, Ladner DP, et al. Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients. Liver Transpl 2015;21:22‐28. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Lieber SR, Volk ML. Non‐adherence and graft failure in adult liver transplant recipients. Dig Dis Sci 2013;58:824‐834. [DOI] [PubMed] [Google Scholar]
